Botulinum Toxin: Approved Uses, Off-Label Uses and Safety

Botulinum Toxin: Approved Uses, Off-Label Uses and Safety

Botulinum toxin is used in aesthetic medicine and across several medical specialties. However, “botulinum toxin” is not one approval for an entire category: each product has its own label, units, indications, age groups, and warnings.

An indication approved for one brand in the United States therefore does not automatically transfer to another brand or establish that the same indication is authorized in Mexico. This guide explains approved and off-label uses without turning patient information into a dosing or injection manual.

---

What is botulinum toxin?

Botulinum toxins are biologic medicines that temporarily reduce signaling between certain nerves and the treated muscle or gland. Depending on the site and indication, this may decrease muscle contraction, sweating, or certain signals involved in a medical disorder.

Botox is a brand of onabotulinumtoxinA, not a generic name for every product. Dysport, Xeomin, and other toxins have different formulations and labeling. Their units are established through each manufacturer's own assay and cannot be directly compared or converted.

Three questions that determine whether a use is approved

Before interpreting a regulatory statement, identify:

1. Which exact product? Authorization for one formulation does not extend to the entire class.
2. Which indication and age group? A brand may be authorized for one area or condition and not another.
3. Which country? The FDA covers the United States; the EMA covers the European Union; and COFEPRIS covers Mexico.

In Mexico, the starting point is the current COFEPRIS health registration and prescribing information for the exact presentation. A U.S. label can provide clinical context, but it does not replace Mexican authorization.

Aesthetic uses

Labels for some products include certain facial lines or neck bands. Authorized areas differ by brand and can change over time.

For example, the current U.S. Botox Cosmetic label includes glabellar lines, crow's feet, forehead lines treated according to its labeled pattern, and vertical platysma bands. The current U.S. Xeomin label includes glabellar lines, horizontal forehead lines, and lateral canthal lines. This describes the United States and those exact products; it is not a list of Mexican authorizations.

Other aesthetic uses discussed during consultation—such as bunny lines, perioral lines, a gummy smile, a “lip flip,” the chin, masseters, or certain asymmetries—may fall outside the product's or country's label. In that situation, the clinician should clearly explain:

• that the proposed use is off-label;
• what evidence and alternatives exist;
• what outcome is realistic;
• which risks are specific to that anatomy;
• and why the expected benefit-risk balance may be reasonable for that person.

Botulinum toxin does not add volume or erase every wrinkle. Lines caused mainly by volume loss, sun damage, or texture changes may require a different approach or may not disappear completely.

Medical uses

Botulinum toxins also have therapeutic uses, but indications are product-specific. Examples in official U.S. labels include:

This table neither recommends treatment nor summarizes every condition in each label. Therapeutic decisions belong with the specialist treating the underlying condition.

What does off-label mean?

An off-label use falls outside the indication, area, age, dose, route, or population described in the applicable label. Evidence quality varies widely: some uses have clinical experience and studies, while others remain preliminary.

Bruxism, myofascial pain, some scars, certain pain syndromes, and applications studied in mental health are examples that may appear in research or clinical practice without becoming a general authorization for “botulinum toxin.” The existence of a study does not establish that a use is equivalent to standard treatment or should replace dental, neurologic, dermatologic, or mental health care.

If off-label treatment is proposed, ask which part is outside the label, what the alternatives are, and what uncertainties remain.

Doses, injection maps, and intervals: why we do not provide a table

No dosing table can safely apply to every brand or patient. Official labels warn that potency units are specific to the product and cannot be compared with or converted into units of another botulinum toxin.

Dose, sites, and intervals also depend on the indication, formulation, anatomy, muscle strength, prior treatment, medical conditions, and medicines. An isolated number found online is not an individualized treatment plan and can increase risk.

Risk of spread of toxin effect

U.S. labels carry a boxed warning about possible spread of toxin effect beyond the treated area. Symptoms have been reported hours to weeks after injection.

Seek immediate medical care for any of the following:

• generalized weakness;
• double or blurred vision, or marked eyelid drooping;
• trouble speaking or a change in voice;
• trouble swallowing;
• shortness of breath or trouble breathing;
• loss of bladder control.

Swallowing and breathing problems can be life-threatening, and deaths have been reported. This risk deserves particular attention in children treated for spasticity and in people with pre-existing neuromuscular, swallowing, or breathing problems.

Side effects and precautions

Pain, tenderness, swelling, or bruising at the injection site and headache can occur. Other effects depend on the treated area—for example, asymmetry, eyelid or brow droop, weakness in nearby muscles, dry eye, smile changes, or trouble chewing or swallowing.

Formal contraindications in the cosmetic labels reviewed include hypersensitivity to botulinum toxin or product components and infection at the proposed injection site. Other circumstances may increase risk or change the plan without being automatic prohibitions:

• a neuromuscular disorder;
• existing swallowing or breathing problems;
• recent treatment with any botulinum toxin;
• injected antibiotics or other medicines that affect neuromuscular transmission;
• previous facial surgery or weakness in the area;
• bleeding disorders or medicines that increase bleeding.

Do not stop prescribed medicines on your own. Bring a complete list of medicines, supplements, and recent treatments to your consultation.

Pregnancy, breastfeeding, and children

Current labels state that human pregnancy and breastfeeding data are inadequate. For an elective aesthetic procedure, postponement is generally prudent. When there is a therapeutic need, the decision should be individualized with the relevant specialist.

Pediatric indications depend on the product, condition, and age. This does not make aesthetic treatment or chronic migraine pediatric indications. Assessment should be performed by a team experienced in the specific condition.

Before treatment

A responsible assessment should confirm the goal, review medical history, examine the area, and document:

• the exact product name and applicable registration;
• previous toxin treatments and their dates;
• medicines, supplements, and allergies;
• neuromuscular disease and breathing or swallowing problems;
• pregnancy, pregnancy plans, or breastfeeding;
• expected benefits, alternatives, risks, and whether the use is off-label.

Effects are not immediate, and their strength and duration vary. Although they usually diminish over time, botulinum toxin cannot be “reversed” on demand as if an aesthetic antidote existed; an adverse effect may require monitoring and treatment.

Authentic products and safer care in Mexico

COFEPRIS maintains a medicine registry and publishes health alerts, including alerts involving illegally marketed botulinum toxin. Before treatment:

• confirm that the product and presentation have a current health registration;
• ask to see the sealed package, lot number, and expiration date;
• avoid untraceable, repackaged products or products obtained outside authorized channels;
• receive treatment only from authorized personnel in a medical setting;
• keep the product name and lot number in your medical record.

An unusually low price, a product without its box, or refusal to identify the brand and lot are reasons not to proceed.